Increased mortality in the A/A genotype of the SNP rs28372698 of interleukin 32
- Urban Alehagen
- Levar Shamoun
- Jan Ingvar Dimberg
- Dick Wågsäter
Affiliations: Division of Cardiovascular Medicine, Department of Medicine and Health Sciences, Faculty of Health Sciences, Linköping University, SE‑581 85 Linköping, Sweden, Division of Medical Diagnostics, Department of Laboratory Medicine, Jönköping County, SE‑553 05 Jönköping, Sweden, Department of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, SE‑553 18 Jönköping, Sweden, Department of Medical Cell Biology, Uppsala University, SE‑752 36 Uppsala, Sweden
- Published online on: December 7, 2020 https://doi.org/10.3892/etm.2020.9559
Copyright: © Alehagen
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
One of the major causes of mortality in the western hemisphere is cardiovascular disease. Therefore, a variety of markers to identify those at risk are required. Interleukin‑32 (IL‑32) is a cytokine that is associated with inflammation. The aim of the current study was to investigate variations in single nucleotide polymorphisms (SNPs) of IL‑32 and plasma expression, and their associations with mortality. A population of 486 elderly community‑living persons were evaluated. The participants were followed for 7.1 years and underwent a clinical examination and blood sampling. SNP analyses of IL‑32 rs28372698 using allelic discrimination and plasma measurement of IL‑32, using ELISA, were performed. During the follow‑up period, 140 (28.8%) all‑cause and 87 (17.9%) cardiovascular deaths were registered. No significant difference between mortality and plasma concentration of IL‑32 was observed. The A/A genotype group exhibited significantly higher all‑cause mortality (P=0.036), and an almost two‑fold increased risk in a multivariate Cox regression model for all‑cause and cardiovascular mortality. A highly significant difference in all‑cause and cardiovascular mortality between the A/A and the T/T groups was demonstrated (P=0.015 resp. P=0.014). In the present study, the cytokine IL‑32 was demonstrated to have prognostic information, with an increased risk of all‑cause and cardiovascular mortality for those with the A/A genotype rs28372698 of IL‑32. The A/A genotype could therefore be regarded as a possible biomarker for mortality risk that may be used to offer optimized cardiovascular patient handling in the future. However, the present study sample was small, and the results should be regarded as hypothesis‑generating.